Abstract

Surgery is the cornerstone treatment for limited stage non-small cell lung cancer and carcinoid tumours, and may be considered for some cases of small-cell lung cancer. Before considering a patient for surgical resection, two points must be taken into account: the resectability – the surgeon’s ability for taking out all the cancer tissue – and the operability – the patient’s ability to tolerate the surgical intervention with adequate recovery and quality of life. Resectability depends on disease extent, while operability’s consequences are measured by the operative risk (mortality and morbidity), taking into account patient’s characteristics: comorbidities, cardiac and respiratory function, and general condition. This article will assess operability, with a particular attention to the cardiorespiratory work-up and decisional algorithms.1877-1203/© 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call